Clinical Trial Update: Companion Protocol for ¹³C-Methacetin Breath Tests in BMS: NCT03486899, NCT03486912 Referenced Trials

View source ↗

Summary

Completed clinical trial related to 13C-Methacetin breath tests in NASH (nonalcoholic steatohepatitis) with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Drugs mentioned

• 13C-Methacetin breath test (13C-Methacetin breath test)

Snippet

Sponsor: Meridian Bioscience, Inc. | Conditions: NASH - Nonalcoholic Steatohepatitis | Status: COMPLETED | Results posted: 2022-08-09